Welcome to Onco Healthmart!

BDR Pharma

Salt: Rucaparib 300mg

Prescription Required: Yes
See Similar Products

Bdparib 300mg Tablet

MRP: ₹54000.00       Discount: 48%
Sale Price:

₹28500.00


Bdparib 300mg Tablet is an anti-cancer agent containing the active constituent rucaparib. It is used for the maintenance treatment of patients with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is used after cancer has responded to previous chemotherapy treatments. It can also be used to treat if your cancer has come back after the chemotherapy and you have an abnormality of the BRCA gene. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner.

Add to Cart

Weight/Quantity: 60 TABLET(s) IN A BOTTLE

Store below 30°C

Bdparib 300mg Tablet is an anti-cancer agent containing the active constituent rucaparib. It is used for the maintenance treatment of patients with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is used after cancer has responded to previous chemotherapy treatments. It can also be used to treat if your cancer has come back after the chemotherapy and you have an abnormality of the BRCA gene. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner.
Bdparib 300mg Tablet is used for treatment of:

Ovarian cancer
Fallopian tube cancer
Primary peritoneal cancer
Take Bdparib 300mg Tablet in a dose and duration prescribed by your doctor
Take Bdparib 300mg Tablet in a dose and duration prescribed by your doctor
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.



Serious:

Fever or infection
Bleeding or bruising
Shortness of breath, having pale skin, or fast heartbeat, feeling tired


Common:

Diarrhea
Nausea, vomiting
Stomach pain
Taste change
Loss of appetite
Dizziness
Heartburn
Sunburn
Rash, itching
Difficulty breathing
High cholesterol levels
Indigestion
Dehydration

Similar Products


©2023 Onco Healthmart. All Rights Reserved. Powered by Hover Business Services LLP.